Recombinant multi-species PDGFRL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDGFRL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein with significant sequence similarity to the ligand binding domain of platelet-derived growth factor receptor beta. Mutations in this gene, or deletion of a chromosomal segment containing this gene, are associated with sporadic hepatocellular carcinomas, colorectal cancers, and non-small cell lung cancers. This suggests this gene product may function as a tumor suppressor. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1110039P19Rik,PDGF receptor beta-like tumor suppressor,PDGFR-like protein,PDGFRL,PDGRL,PRLTS,Pdgfrl,Platelet-derived growth factor receptor-like protein

Target products collectionGo to PDGFRL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1177-Ag-1/ GM-Tg-hg-SE1177-Ag-2 Human PDGFRL protein Human
GM-Tg-rg-SE1177-Ag-1/ GM-Tg-rg-SE1177-Ag-2 Rat PDGFRL protein Rat
GM-Tg-mg-SE1177-Ag-1/ GM-Tg-mg-SE1177-Ag-2 Mouse PDGFRL protein Mouse
GM-Tg-cynog-SE1177-Ag-1/ GM-Tg-cynog-SE1177-Ag-2 Cynomolgus/Rhesus macaque PDGFRL protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1177-Ag-1/ GM-Tg-felg-SE1177-Ag-2 Feline PDGFRL protein Feline
GM-Tg-cang-SE1177-Ag-1/ GM-Tg-cang-SE1177-Ag-2 Canine PDGFRL protein Canine
GM-Tg-bovg-SE1177-Ag-1/ GM-Tg-bovg-SE1177-Ag-2 Bovine PDGFRL protein Bovine
GM-Tg-equg-SE1177-Ag-1/ GM-Tg-equg-SE1177-Ag-2 Equine PDGFRL protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1177-Ag-1/ GM-Tg-hg-SE1177-Ag-2; GM-Tg-rg-SE1177-Ag-1/ GM-Tg-rg-SE1177-Ag-2;
GM-Tg-mg-SE1177-Ag-1/ GM-Tg-mg-SE1177-Ag-2; GM-Tg-cynog-SE1177-Ag-1/ GM-Tg-cynog-SE1177-Ag-2;
GM-Tg-felg-SE1177-Ag-1/ GM-Tg-felg-SE1177-Ag-2; GM-Tg-cang-SE1177-Ag-1/ GM-Tg-cang-SE1177-Ag-2;
GM-Tg-bovg-SE1177-Ag-1/ GM-Tg-bovg-SE1177-Ag-2; GM-Tg-equg-SE1177-Ag-1/ GM-Tg-equg-SE1177-Ag-2
Products Name PDGFRL protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PDGFRL
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDGFRL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.